person · Reporting owner
McManus Joseph Richard Jr.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEST CORPINTT · Entity 6590 | Division Pres-Electronic Test | April 28, 2026 | April 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEST CORP
Report date April 28, 2026 · Filed April 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,460 |
Reported balance
After 2026-04-28 transaction · row 1
1 source rowRow 1 · 2026-04-28 · Tax withholding · Disposed 233 · Balance 35,460 F1: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock on April 28, 2026. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.47 · Expires 2036-03-15 | Direct | 4,284 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,284 F2: This option vests in four equal annual installments commencing on March 16, 2027. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.74 · Expires 2035-03-16 | Direct | 2,006 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 2,006 F3: This option vests in four equal annual installments commencing on March 17, 2026. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.74 · Expires 2035-03-16 | Direct | 7,954 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 7,954 F3: This option vests in four equal annual installments commencing on March 17, 2026. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.33 · Expires 2034-03-05 | Direct | 5,600 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 5,600 F4: This option vests in four equal annual installments commencing on March 6, 2025. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.06 · Expires 2033-03-07 | Direct | 3,576 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 3,576 F5: This option vests in four equal annual installments commencing on March 8, 2024. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.14 · Expires 2032-04-27 | Direct | 13,880 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 13,880 F6: This option is fully vested as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.13 · Expires 2031-04-27 | Direct | 10,000 |
Reported balance
Holding disclosure · report date 2026-04-28 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,000 F6: This option is fully vested as of the date of this report. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock on April 28, 2026.
F2: This option vests in four equal annual installments commencing on March 16, 2027.
F3: This option vests in four equal annual installments commencing on March 17, 2026.
F4: This option vests in four equal annual installments commencing on March 6, 2025.
F5: This option vests in four equal annual installments commencing on March 8, 2024.
F6: This option is fully vested as of the date of this report.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 28, 2026 Filed Apr 29, 2026 20:05 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 233 | $16.90 | $3,937.70 |
DisclosureSEC source: 0000891839-26-000145 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,460 F1 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock on April 28, 2026. Read SEC document |
| March 17, 2026 Filed Mar 18, 2026 21:03 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 296 | $14.46 | $4,280.16 |
DisclosureSEC source: 0000891839-26-000097 · form4.xml · nonDerivative · entry 3 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,693 F3 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock on March 17, 2026. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:03 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 4,284 | $0.00 Strike: $14.47 | $0.00 |
DisclosureSEC source: 0000891839-26-000097 · form4.xml · derivative · entry 4 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,284 Underlying: Common Stock · 4,284 shares Expires 2036-03-15 F4 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:03 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 2,535 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000097 · form4.xml · nonDerivative · entry 2 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,989 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in March 2029 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 3,803 Read SEC document |
| March 16, 2026 Filed Mar 18, 2026 21:03 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 2,535 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000097 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,454 F1 · shares: These restricted shares were granted pursuant to the InTest Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. Read SEC document |
| March 08, 2026 Filed Mar 10, 2026 23:34 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 130 | $13.24 | $1,721.20 |
DisclosureSEC source: 0000891839-26-000077 · form4.xml · nonDerivative · entry 2 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,919 F1 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 23:34 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 203 | $13.24 | $2,687.72 |
DisclosureSEC source: 0000891839-26-000077 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,049 F1 · shares: These shares were withheld to cover tax withholding obligations on the vesting of restricted stock. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:30 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0000891839-26-000071 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,252 F1 · shares: Shares forfeited under the terms of Mr. McManus's performance-based restricted stock award granted on March 8, 2023. Read SEC document |
| March 17, 2025 Filed Mar 20, 2025 00:12 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 7,954 | $0.00 Strike: $7.74 | $0.00 |
DisclosureSEC source: 0001062993-25-005944 · form4.xml · derivative · entry 4 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,954 Underlying: Common Stock · 7,954 shares Expires 2035-03-16 F4 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Mar 20, 2025 00:12 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 2,006 | $4.61 Strike: $7.74 | $9,247.66 |
DisclosureSEC source: 0001062993-25-005944 · form4.xml · derivative · entry 3 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,006 Underlying: Common Stock · 2,006 shares Expires 2035-03-16 F3 · price: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $9,246. This option will vest in four equal annual installments commencing on March 17, 2026. F3 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $9,246. This option will vest in four equal annual installments commencing on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Mar 20, 2025 00:12 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 4,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005944 · form4.xml · nonDerivative · entry 2 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,328 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 17, 2028 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 7,107. Read SEC document |
| March 17, 2025 Filed Mar 20, 2025 00:12 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 4,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-005944 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,590 F1 · shares: These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 5,600 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001062993-24-005988 · form4.xml · derivative · entry 3 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,600 Underlying: Common Stock · 5,600 shares Expires 2034-03-05 F3 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005988 · form4.xml · nonDerivative · entry 2 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,852 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 6, 2027 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 4,854. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 3,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005988 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,616 F1 · shares: These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 6, 2025. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:40 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 3,576 | $0.00 Strike: $16.06 | $0.00 |
DisclosureSEC source: 0001062993-23-006634 · form4.xml · derivative · entry 3 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,576 Underlying: Common Stock · 3,576 shares Expires 2033-03-07 F3 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:40 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006634 · form4.xml · nonDerivative · entry 2 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,380 F2 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 8, 2026 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 3,114. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:40 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 2,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006634 · form4.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,304 F1 · shares: These restricted shares were granted pursuant to the Issuer's Fourth Amended and Restated 2014 Stock Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:27 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 13,880 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001036262-22-000011 · primary_doc.xml · derivative · entry 2 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,880 Underlying: Common Stock · 13,880 shares Expires 2032-04-27 F2 · derivative.exercise_date: The option was issued pursuant to the Stock Plan and will vest 25% annually commencing on April 28, 2023. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:27 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 3,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-22-000011 · primary_doc.xml · nonDerivative · entry 1 McManus Joseph Richard Jr. · CIK 0001918873 · Division Pres-Electronic Test 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,228 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan (the "Stock Plan") and will vest 25% annually commencing on April 28, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.